Despite the critical roles of VEGF and the frequently mutation of p53 in pancreatic cancer, whether this type of modulation contributes to elevated EDIL3 expression remains further investigation [29–33]. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.